Nuance Mid Cap Value Z holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Nuance Mid Cap Value Fund Z Class Shares NMVZX
- NAV / 1-Day Return $13.87 / +0.22 %
- Fund Size $269.8M
- Adjusted Expense Ratio 0.810%
- Net Expense Ratio 0.790%
- Fee Level: Distribution Average
- Share Class Type Institutional
- Morningstar Category Mid-Cap Value
- Equity Style Box (Funds) Mid Value
- Minimum Initial Investment $2,500
- Investment Status Open
- TTM Yield 1.31%
- Turnover Ratio 110%
Morningstar’s Analysis NMVZX
Will NMVZX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 42.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Qiagen NV | 7.24 | 21M | Healthcare |
First American Government Obligs X | 6.65 | 19M | Cash and Equivalents |
California Water Service Group | 5.86 | 17M | Utilities |
Beiersdorf AG ADR | 5.74 | 17M | Consumer Defensive |
Clorox Co | 5.31 | 16M | Consumer Defensive |
Kenvue Inc | 3.51 | 10M | Consumer Defensive |
Charles Schwab Corp DR | 3.39 | 10M | Financial Services |
Solventum Corp | 3.03 | 9M | Healthcare |
Bio-Techne Corp | 3.00 | 9M | Healthcare |
Henkel AG & Co KGaA ADR | 2.80 | 8M | Consumer Defensive |